These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1279830)

  • 21. [The use of dalargin for treating recurrent aphthous stomatitis].
    Maksimovskaia LN
    Stomatologiia (Mosk); 1995; 74(4):15. PubMed ID: 7502297
    [No Abstract]   [Full Text] [Related]  

  • 22. [The efficacy of treating peptic ulcer patients with trichopol and dalargin].
    Lukash NV; Buglak NP; Kriuchkova ON; Lukash SN; Maloshenko SI
    Lik Sprava; 1992 Feb; (2):35-7. PubMed ID: 1441328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A clinico-laboratory assessment of the efficacy of dalargin in treating acute suppurative-inflammatory processes in the maxillofacial area].
    Bazhanov NN; Ganina SS; Ragimov ChR; Pashutin SB; Brusina LI
    Stomatologiia (Mosk); 1993; 72(4):22-5. PubMed ID: 8108814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of a dalargin aerosol in treating the exacerbations of uncomplicated duodenal peptic ulcer].
    Buglak NP; Bogdanov NN; Vinogradov VA; Titov MI
    Vopr Kurortol Fizioter Lech Fiz Kult; 1988; (4):19-25. PubMed ID: 3195111
    [No Abstract]   [Full Text] [Related]  

  • 25. [The efficacy of using dalargin electrophoresis in the combined treatment of patients with ischemic heart disease].
    Ilaev TM; Ratner ZG
    Lik Sprava; 1998; (2):74-7. PubMed ID: 9670662
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of tageflar, a synthetic analog of L-enkephalin, on the morphogenesis of experimental pancreatitis].
    Kanaian AS; Permiakov NK; Titova GP; Golovleva GM; Arabadzhian KP
    Biull Eksp Biol Med; 1987 Nov; 104(11):599-602. PubMed ID: 3676499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of dalargin in the intensive therapy of critical conditions].
    Smirnova VI; Pulina NN; Kazennov VV; Oranskiĭ AV; Smirnov EP
    Vestn Ross Akad Med Nauk; 1994; (6):48-51. PubMed ID: 7522704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The evaluation of the efficacy of dalargin treatment in patients with face and neck phlegmons by the free-radical oxidation indices of the peripheral blood].
    Ganina SS; Ragimov ChR
    Stomatologiia (Mosk); 1991; (6):28-30. PubMed ID: 1803645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Gastrointestinal endocrine cells during the treatment of duodenal ulcer patients with the new peptide preparation dalargin].
    Zverkov IV; Arndt IP; Shcherbakova NV; Smagin VG
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):72-4. PubMed ID: 2879547
    [No Abstract]   [Full Text] [Related]  

  • 30. [The mechanism of the action of dalargin in experimental myocardial ischemia].
    Mikhaĭlova SD; Storozhakov GI; Bebiakova NA; Glushchenko NV; Semushkina TM
    Biull Eksp Biol Med; 1992 Oct; 114(10):345-7. PubMed ID: 1288681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The antioxidant action of dalargin on the liver in experimental acute cholestasis].
    Korotkina RN; Fomchenkov EP; Babkina NV; Andreev VI; Shloznikov BM; Karelin AA
    Patol Fiziol Eksp Ter; 1990; (4):42-4. PubMed ID: 2080086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The clinico-laboratory assessment of the efficacy of dalargin in treating acute suppurative-inflammatory processes of the maxillofacial area].
    Bazhanov NN; Ganina SS; Pashutin SB; Ragimov ChR
    Sov Med; 1991; (7):29-31. PubMed ID: 1948337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of dalargin on repair capacity of gastroduodenal mucosa in patients with duodenal ulcer].
    Timoshin SS; Alekseenko SA; Shtuka AA
    Klin Med (Mosk); 1991 Mar; 69(3):75-7. PubMed ID: 2067344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of dalargin on the course of combined radiation lesions (experimental research)].
    Legeza VI; Zhiliaev EG; Koshcheev AG; Konovalova LI
    Voen Med Zh; 1993 May; (5):19-21. PubMed ID: 8356812
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of dalargin on the level of gastric secretion].
    Tepliuk SG
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):67-8. PubMed ID: 3801139
    [No Abstract]   [Full Text] [Related]  

  • 36. [The mechanism of the antiarrhythmic action of dalargin in experimental myocardial ischemia].
    Maslov LN; Lishmanov IuB
    Eksp Klin Farmakol; 1992; 55(2):25-8. PubMed ID: 1358376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dalargin in the treatment of arteriosclerosis obliterans of the lower extremities].
    Dudko VA; Fedorova NA; Didenko VA; Zoloev GK
    Sov Med; 1990; (2):90-2. PubMed ID: 2192476
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of dalargin as a component of postoperative analgesia in middle-aged and aged persons].
    Malyshev VD; Slastnikov SV; Sviridov SV; Bocharov VA; Mel'nik OB; Kasimov AO
    Anesteziol Reanimatol; 1995; (1):66-8. PubMed ID: 7605044
    [No Abstract]   [Full Text] [Related]  

  • 39. Serum amylases and their inhibitors: 2. Clinical and experimental +obersvations--diet and steroid effects.
    Tuzhilin SA; Gonda M; Carbonell G; Dreiling DA
    Am J Gastroenterol; 1982 Jan; 77(1):26-8. PubMed ID: 6175206
    [No Abstract]   [Full Text] [Related]  

  • 40. [The effect of dalargin on the hemodynamics in acute myocardial infarct complicated by clinical death].
    Lisachenko GV; Slepushkin VD; Zoloev GK
    Anesteziol Reanimatol; 1992; (4):57-9. PubMed ID: 1485679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.